VDAC1 and cancer: Collectively, our results demonstrate that structure and bioactivity‐guided synthesized new compounds intersect at the VDAC1/PHB/MMP9 crossroads and exhibit cancer‐specific cytotoxic properties, inducing apoptosis and suppressing the energy metabolism and stemness of CRC.